SelectQuote (NYSE:SLQT - Get Free Report) issued its quarterly earnings results on Monday. The company reported $0.03 EPS for the quarter, missing analysts' consensus estimates of $0.04 by ($0.01), Zacks reports. The company had revenue of $408.16 million during the quarter, compared to the consensus estimate of $412.83 million. SelectQuote had a negative return on equity of 4.38% and a negative net margin of 0.95%. SelectQuote updated its FY 2025 guidance to EPS.
SelectQuote Price Performance
SLQT traded down $0.01 on Thursday, hitting $2.32. 1,380,724 shares of the company's stock traded hands, compared to its average volume of 1,415,385. The firm has a market cap of $399.37 million, a price-to-earnings ratio of -25.78 and a beta of 1.26. The company's 50 day simple moving average is $3.21 and its 200-day simple moving average is $3.49. The company has a current ratio of 6.36, a quick ratio of 6.36 and a debt-to-equity ratio of 2.10. SelectQuote has a one year low of $1.62 and a one year high of $6.86.
Insiders Place Their Bets
In other SelectQuote news, insider Sarah Taylor Anderson sold 50,000 shares of the firm's stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $5.44, for a total transaction of $272,000.00. Following the transaction, the insider now owns 1,166 shares of the company's stock, valued at approximately $6,343.04. This trade represents a 97.72% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 11.40% of the company's stock.
Analyst Ratings Changes
Separately, Noble Financial raised shares of SelectQuote to a "strong-buy" rating in a research note on Wednesday, February 12th.
Check Out Our Latest Stock Analysis on SLQT
SelectQuote Company Profile
(
Get Free Report)
SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.
See Also

Before you consider SelectQuote, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SelectQuote wasn't on the list.
While SelectQuote currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.